Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Abitate U 250 mg Tablet
Manufacturer/Marketed By : Rpg Life Sciences Ltd
$176.79 $155.58
Abitate U 250 mg Tablet is a specialized medication utilized in conjunction with corticosteroids like prednisone or methylprednisolone for the management of advanced prostate cancer in adult males. This treatment...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Abiraterone Acetate 250 mg
Active Pharmaceutical Ingredient
Abitate U 250 mg Tablet
176.79$
155.58$
Abitate U 250 mg Tablet is a specialized medication utilized in conjunction with corticosteroids like prednisone or methylprednisolone for the management of advanced prostate cancer in adult males. This treatment is particularly beneficial for patients whose cancer has metastasized and who have not experienced adequate results from conventional therapies, such as chemotherapy. By inhibiting the production of testosterone, Abitate U effectively slows down the progression of prostate cancer, offering a strategic approach to controlling this condition. It is crucial for patients to discuss their full medical history and any potential side effects with their healthcare provider before starting this therapy. Additionally, Abitate U is not suitable for everyone, and close monitoring is essential to ensure optimal effectiveness and safety. If you or a loved one is exploring treatment options for prostate cancer, Abitate U may offer a promising solution when used as part of a comprehensive treatment plan. Always consult with a healthcare professional to determine the best course of action tailored to individual needs.
Active Pharmaceutical Ingredient
Uses
• Abitate u 250 mg tablet is primarily used in the treatment of prostate cancer, a prevalent condition affecting the male reproductive system. This medication helps manage the growth of cancer cells within the prostate gland. By inhibiting certain hormones, Abitate u 250 mg tablet can slow down the progression of the disease. Patients often benefit from this treatment as part of a comprehensive cancer management plan.
• The use of Abitate u 250 mg tablet is essential for patients experiencing advanced stages of prostate cancer. In these cases, the medication works by reducing testosterone levels, which can fuel the growth of cancer cells. This therapeutic approach helps to control symptoms associated with the disease. Many healthcare providers recommend Abitate u 250 mg tablet as a pivotal component of treatment regimens.
• In addition to its role in managing prostate cancer, Abitate u 250 mg tablet may be prescribed for patients undergoing hormone therapy. It aids in enhancing the effectiveness of other treatments by targeting hormonal pathways involved in cancer progression. This makes Abitate u 250 mg tablet an integral part of personalized treatment plans for individuals facing complex cancer scenarios. By addressing hormonal influences, it helps improve overall patient outcomes.
• Abitate u 250 mg tablet is often utilized in combination with other cancer therapies to optimize treatment results. This medication can help reduce the risk of cancer recurrence in patients who have undergone surgery or radiation. By managing hormone levels, Abitate u 250 mg tablet contributes to a multi-faceted approach in treating prostate cancer. Clinicians may recommend this medication to enhance the efficacy of ongoing cancer care.
Benefits
Abitate U 250 mg Tablet decreases the production of testosterone in males. In this way, the cancer cells decrease or stop growing due to low testosterone levels in the body.
Abitate U Anti-cancer Tablet can slow the growth of prostate cancer cells and reduce the size of tumors.
Abiraterone Acetate 250 mg Tablet can delay the need for other treatments such as chemotherapy or radiation therapy and prolong survival in people with advanced prostate cancer.
Side Effects
Abitate U 250 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Urinary tract infection
• Hypokalemia
• Hypertension
• Diarrhoea
• Peripheral oedema
Common Side Effects
• Hypertriglyceridaemia
• Sepsis
• Cardiac failure
• Angina pectoris
• Arrhythmia
• Atrial fibrillation
• Tachycardia
• Dyspepsia (indigestion)
• Rash
• Alanine aminotransferase increased
• Fatigue
• Joint pain
• Hot flashes
• Nausea
How To Use
Abitate U 250 mg Tablet taken by mouth once a day on an empty stomach. Do not eat food 2 hours before and 1 hour after taking Abitate U 250 mg. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses simultaneously to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Abitate U 250 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Abitate U 250 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Abitate U 250 mg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Abitate U for prostate cancer. Abitate U 250 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Abitate U 250 mg Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Abitate U 250 mg Tablet if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Abitate U 250 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Abitate U 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Abitate U 250 mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Abitate U for prostate cancer, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.